Published in J Med Entomol on October 12, 1979
Human impacts have shaped historical and recent evolution in Aedes aegypti, the dengue and yellow fever mosquito. Evolution (2013) 1.42
History of domestication and spread of Aedes aegypti--a review. Mem Inst Oswaldo Cruz (2013) 1.40
Gene flow, subspecies composition, and dengue virus-2 susceptibility among Aedes aegypti collections in Senegal. PLoS Negl Trop Dis (2009) 1.36
The Harmonic Convergence of Fathers Predicts the Mating Success of Sons in Aedes aegypti. Anim Behav (2011) 1.04
Global genetic diversity of Aedes aegypti. Mol Ecol (2016) 0.78
Reproductive Incompatibility Involving Senegalese Aedes aegypti (L) Is Associated with Chromosome Rearrangements. PLoS Negl Trop Dis (2016) 0.78
Multiple QTL Determine Dorsal Abdominal Scale Patterns in the Mosquito Aedes aegypti. J Hered (2016) 0.76
Exon-Enriched Libraries Reveal Large Genic Differences Between Aedes aegypti from Senegal, West Africa, and Populations Outside Africa. G3 (Bethesda) (2017) 0.75
Population genomics reveals that an anthropophilic population of Aedes aegypti mosquitoes in West Africa recently gave rise to American and Asian populations of this major disease vector. BMC Biol (2017) 0.75
Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by amplification of rRNA. J Clin Microbiol (1993) 6.38
Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA (2001) 5.54
Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial. J Clin Oncol (2001) 4.73
Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24
Comparison of human fibroblast cells and primary rabbit kidney cells for isolation of herpes simplex virus. J Clin Microbiol (1984) 2.22
Office-based test systems for HIV antibody. N Engl J Med (1993) 2.02
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Blood Cells Mol Dis (2000) 1.61
Enhanced endothelium-dependent vasodilation in Fabry disease. Stroke (2001) 1.56
Enumeration and speciation of enterococci found in marine and intertidal sediments and coastal water in southern California. J Appl Microbiol (2005) 1.50
Evidence for neuroaxonal injury in patients with proteolipid protein gene mutations. Neurology (2001) 1.42
Comparison of total coliform, fecal coliform, and enterococcus bacterial indicator response for ocean recreational water quality testing. Water Res (2003) 1.38
Rapid herpes simplex virus detection in clinical samples submitted to a state virology laboratory. J Clin Microbiol (1985) 1.35
Evaluation of a deoxyribonucleic acid probe for the detection of Trichomonas vaginalis in vaginal secretions. Am J Obstet Gynecol (1996) 1.19
Subarachnoid haemorrhage associated with MDMA abuse. J Neurol Neurosurg Psychiatry (1993) 1.11
Amebiasis in northern Saskatchewan: pathological aspects. Can Med Assoc J (1968) 1.03
Enzyme replacement therapy in Fabry disease. J Inherit Metab Dis (2001) 1.02
Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease. Neurology (2006) 1.00
Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant (1997) 1.00
A proportional hazards model for truncated AIDS data. Biometrics (1993) 0.98
Clinical use of diffusion-tensor imaging for diseases causing neuronal and axonal damage. AJNR Am J Neuroradiol (1999) 0.98
Targeted HIV seroprevalence among Vietnamese in southern California. Genitourin Med (1994) 0.93
Neuropathic and cerebrovascular correlates of hearing loss in Fabry disease. Brain (2006) 0.92
Monoclonal macroglobulinemia in malignant lymphoma. Ann Intern Med (1970) 0.91
Using strain typing to characterise a fluoroquinolone-resistant Neisseria gonorrhoeae transmission network in southern California. Sex Transm Infect (2008) 0.90
Isolation of Mycobacterium thermoresistibile following augmentation mammaplasty. J Clin Microbiol (1992) 0.89
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. Ann Oncol (2003) 0.88
Glutathione S-transferase activity and glutathione S-transferase mu expression in subjects with risk for colorectal cancer. Cancer Res (1995) 0.88
Experimental withdrawal of lithium in recovered manic-depressive patients: a report of five cases. Am J Psychiatry (1971) 0.88
The fate of the mentally ill physician. Am J Psychiatry (1969) 0.87
Treatment profile and complications associated with cryotherapy for localized prostate cancer: a population-based study. Prostate Cancer Prostatic Dis (2011) 0.86
Growth studies on Mycobacterium BCG: oxygen preference. Microbios (1982) 0.85
Evaluation of docetaxel in previously untreated extensive-stage small cell lung cancer: a Southwest Oncology Group phase II trial. Cancer J Sci Am (1999) 0.85
Gemcitabine and oxaliplatin for patients with advanced or metastatic pancreatic cancer: a North Central Cancer Treatment Group (NCCTG) phase I study. Ann Oncol (2002) 0.85
A phase II trial of etoposide, leucovorin, 5-FU, and interferon alpha 2b (ELFI) + G-CSF for patients with pancreatic adenocarcinoma: a Southwest Oncology Group study (SWOG 9413). Invest New Drugs (2000) 0.84
13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Gynecol Oncol (1998) 0.83
Phase II evaluation of interleukin-4 in patients with non-Hodgkin's lymphoma: a Southwest Oncology Group trial. Anticancer Drugs (2000) 0.82
Significant elimination of bismuth by haemodialysis with a new heavy-metal chelating agent. Nephrol Dial Transplant (1995) 0.82
Local and global cerebral blood flow and glucose utilization in the alpha-galactosidase A knockout mouse model of Fabry disease. J Neurochem (2001) 0.82
Cancer in families with systemic sclerosis. Am J Med Sci (1995) 0.81
Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine. Curr Ther Res Clin Exp (1975) 0.79
Phase II trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma. Invest New Drugs (1999) 0.79
Physical dynamics controlling variability in nearshore fecal pollution: fecal indicator bacteria as passive particles. Mar Pollut Bull (2012) 0.78
Evaluation of Tomudex in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Southwest Oncology Group study. Invest New Drugs (1999) 0.78
Phase II trial of oral etoposide in recurrent or refractory endometrial adenocarcinoma: a southwest oncology group study. Gynecol Oncol (1999) 0.78
Follow-up of stereotaxic amygdalotomy for seizure and behavior disorders. Biol Psychiatry (1977) 0.77
Effect of educational program on compliance with glove use in a pediatric emergency department. Am J Dis Child (1992) 0.77
Integration and transcription of virus DNA in herpes simplex virus transformed cell lines. J Gen Virol (1980) 0.76
Familial associations with EEG variants in manic-depressive disease. Arch Gen Psychiatry (1975) 0.76
Follow-up of University of Virginia experience with the modified Lothrop procedure. Am J Rhinol (1997) 0.76
Herpes simplex virus necleic acid synthesis following infection of non-permissive XC cells. J Gen Virol (1978) 0.76
EEG and neurophysiological studies of lithium in normal volunteers. Biol Psychiatry (1972) 0.76
Virus inhibition assay for measurement of acyclovir levels in human plasma and urine. Antimicrob Agents Chemother (1981) 0.75
Predominant downgaze ophthalmoparesis in anti-Hu encephalomyelitis. J Neuroophthalmol (1996) 0.75
The effect of thalidomide on the developing rat foetus. Br J Exp Pathol (1967) 0.75
Isolation of Borrelia burgdorferi from ticks in southern California. West J Med (1992) 0.75
A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas. Invest New Drugs (1994) 0.75
Organ preservation using ultrabaric oxygen. Nature (1966) 0.75
The history and development of the BCG. Practitioner (1983) 0.75
Factors controlling variability in nearshore fecal pollution: the effects of mortality. Mar Pollut Bull (2012) 0.75
Dr. Allan A. Bailey. Can Med Assoc J (1967) 0.75
A double-blind comparative evaluation of flurothyl and ECT. Arch Gen Psychiatry (1968) 0.75
Recombinant interleukin-2 in combination with recombinant interferon-gamma in patients with advanced malignancy: a phase 1 study. J Immunother (1997) 0.75
Interleukin-1 alpha administration increases oral granulocytes and epithelial cells. J Infect Dis (1994) 0.75
Stiripentol in acute/chronic efficacy tests in monkey model. Epilepsia (1986) 0.75
Modulation of fluorouracil with recombinant alfa interferon: M. D. Anderson Clinical trial. Semin Oncol (1992) 0.75
Passive-aggressive personality disorder: a search for a syndrome. Am J Psychiatry (1970) 0.75
Eating fresh coffee grounds: psychoneurosis or sub-clinical pellagra. J Tenn Med Assoc (1973) 0.75
Growth studies on Mycobacterium BCG: establishment of growth curves and measurement of the oxygen tension of the growth medium. Microbios (1982) 0.75
Clinical trials of fluorouracil with alpha-interferon in advanced colorectal carcinomas. Semin Oncol (1991) 0.75
Phase II study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481). Leuk Lymphoma (1998) 0.75
Phase II trial of edatrexate in patients with advanced hepatocellular carcinoma. Ann Oncol (1994) 0.75
Simultaneous magnetically directed drug convection and MR imaging. Nanotechnology (2009) 0.75
Gailor Mental Health Center Sociopathic personality. J Tenn Med Assoc (1968) 0.75